SNPS vs TERN · P/E 63, rev $7.05B vs $6.12B cap
Synopsys Inc (SNPS) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
SNPS currently screens at market cap $85.14B and trailing P/E 63.3. TERN currently screens at market cap $6.12B.
Not investment advice. Open the SNPS and TERN stock pages for the full models.
Not investment advice.